GalNAc Cluster Amide C7 Linker DMT Succinate Macroporous Aminomethyl Resin
| Catalog No. | ON-821 |
| Purity | UPLC≥98% |
| Storage Condition | 2-8℃ |
GalNAc Cluster Amide C7 Linker DMT Succinate Macroporous Aminomethyl Resin
GalNAc Cluster Amide C7 Linker DMT Succinate Macroporous Aminomethyl Resin - N (Normal) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Specifications
Specifications
-
Catalog No.ON-821
-
SMILESO=C(COCCOCCOCCO[C@@H]1O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1NC(C)=O)NCCCC[C@@H](C(NCCCCC(COC(CCC(NC)=O)=O)COC(C2=CC=CC=C2)(C3=CC=C(OC)C=C3)C4=CC=C(OC)C=C4)=O)NC([C@H](CCCCNC(COCCOCCOCCO[C@@H]5O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]5NC(C)=O)=O)NC(COCCOCCOCCO[C@@H]6O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]6NC(C)=O)=O)=O
-
AppearanceWhite to off-white powder, free from visible foreign matter
-
PurityUPLC≥98%
-
Storage Condition2-8℃
Documentation
Documentation
-
Catalog No.ON-821
-
SMILESO=C(COCCOCCOCCO[C@@H]1O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1NC(C)=O)NCCCC[C@@H](C(NCCCCC(COC(CCC(NC)=O)=O)COC(C2=CC=CC=C2)(C3=CC=C(OC)C=C3)C4=CC=C(OC)C=C4)=O)NC([C@H](CCCCNC(COCCOCCOCCO[C@@H]5O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]5NC(C)=O)=O)NC(COCCOCCOCCO[C@@H]6O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]6NC(C)=O)=O)=O
-
AppearanceWhite to off-white powder, free from visible foreign matter
-
PurityUPLC≥98%
-
Storage Condition2-8℃
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
